We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Vitro Sociedad Ads | NYSE:VTO | NYSE | Ordinary Share |
Price Change | % Change | Share Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 0.00 | - |
File No. 1-10905
SECURITIES AND EXCHANGE
COMMISSION
Washington, D.C. 20549
VITRO, S.A.B.
DE C.V.
FORM 6-K
Report of Foreign
Issuer
Pursuant to Rule 13a-16 or 15d-16 of
the Securities Exchange Act of
1934
For the month of March, 2009
(Filed March 30, 2009)
N/A
(Translation of
Registrant's Name into English)
Av. Ricardo Margain Zozaya 400
Garza
Garcia, NL
66250 Mexico
(52) 8863-1200
(Address of Principal Executive
Office)
Indicate by check mark whether the registrant files or
will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ X ] Form 40-F [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): [ ]
Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 107(b)(7): [ ]
Indicate by check mark whether the registrant by furnishing the information contained in this form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934
Yes [ ] No [ X ]
Release
Vitro Reports 4Q' 08 Declines of 18.2% and 41.8% in Sales and EBITDA
San Pedro Garza Garcia, Nuevo
Leon, Mexico, March 30, 2009.- Vitro, S.A.B. de C.V. (NYSE: VTO; BMV: VITROA),
one of the world's largest producers and distributors of glass products,
today announced 4Q'08 unaudited results. Year over year consolidated net sales
declined 18.2 percent mostly affected
by a 28.2 percent peso depreciation during the quarter while EBITDA decreased
41.8 percent. The consolidated EBITDA margin decreased to 10.9 percent from 15.3
percent in the same period last year.
Commenting on the results for the quarter, Mr. Hugo Lara, Chief Executive
Officer, said, "This was a difficult quarter for Vitro as the worldwide
recession and tight credit markets clearly impacted results. It is also
clear that Vitro's strong market position and franchise, a long standing
diversified blue chip client base and the investments in our manufacturing
facilities over the past ten years constitute an important foundation in
these challenging times. But most importantly, we are confident we are
taking all the necessary steps to continue business as usual although at a
lower capacity while maintaining ongoing relationships with customers and
suppliers. In fact, we are focused on actively controlling costs, managing
our liquidity, and generating cash flow, while we restructure our
financial obligations."
Mr. Claudio del Valle, Chief Administrative and Financial Officer, commented,
"In the face of global declining demand, Glass Container sales volumes were
down in all segments reflecting overall weak conditions. As a result,
domestic and export sales declined year-over-year by 16.9 percent and 14.1
percent, respectively. While EBITDA benefited somewhat by cost reduction
initiatives we reported a 34.2 percent year-over-year drop for glass
containers. On a comparable basis, excluding Comegua which was
deconsolidated since December 2008, EBITDA would have decreased 30.7 percent
YoY. Looking forward, our goal is to optimize production lines to assure
continuity and have launched several programs to increase volumes."
"Flat Glass sales fell
18 percent this quarter mainly driven by continued
tough industry conditions in the North American Automotive business, as well
as the US and Spanish construction segments. In the Mexican construction
market, we maintained our market share despite an industry wide volume
decrease. Auto glass volumes to the OEM market fell 10 percent in the face
of a 26 percent industry drop as a result of weakening demand, which
translated into a market share gain from 14 percent to 17 percent in the
NAFTA region. Float glass exports remained strong with volume up 22 percent
year-over-year. EBITDA, in turn, declined during the period, mainly as a
result of lower fixed-cost absorption. Looking ahead, our goal is to build
sales through marketing programs for the domestic automotive glass
replacement aftermarket, expansion of Vitro Cristalglass product offerings,
increasing float glass exports to new markets. For Vitro America, the focus
is on value added products and areas where we can differentiate our products.
In all Flat Glass, we are analyzing demand and expect to rationalize
capacity where required."
Addressing the restructuring process, Mr. Lara commented,
"Today we are in
the process of negotiations with counterparties to determine alternatives
for restructuring derivative obligations. An additional element of the
restructuring involves our bondholders and other financial counterparties. A
committee has been formed and we have been negotiating with bondholders. At
this point, we are in the process of developing a business plan that
outlines our strategy and expected performance which will be presented to
creditors in the next few weeks."
"We have also taken steps to revitalize the Company, including cost
reduction initiatives throughout every aspect of our company, while
optimizing production capacity to maximize utilization and efficiencies
consistent with the current level of operations. Together, these initiatives
will represent annualized savings of between US$80 and US$120 million once
fully implemented. During 2008, US$40 million were implemented and will have
their full benefit in 2009. To further maximize our cash position we have
also reduced capital expenditures to US$74 million for 2009 and sold several
minor non-productive assets."
"In summary, we are taking decisive steps to better position Vitro for the
future and will continue to maintain constant communication with creditors,
financial institutions, clients and suppliers as we advance our plans in
2009," Mr. Lara closed.
All figures provided in this announcement are in accordance with Mexican
Financial Reporting Standards (Mexican FRS or NIFs) issued by the Mexican Board
for Research and Development of Financial Reporting Standards (CINIF), except
otherwise indicated. Dollar figures are in nominal US dollars and are obtained
by dividing nominal pesos for each month by the end of month fix exchange rate
published by Banco de Mexico. In the case of the Balance Sheet, US dollar
translations are made at the fix exchange rate as of the end of the
period. Certain amounts may not sum due to rounding. All figures and
comparisons are in US dollar terms, unless otherwise stated, and may differ from
the peso amounts due to the difference between inflation and exchange
rates.
This announcement
contains historical information, certain management's expectations, estimates
and other forward-looking information regarding Vitro, S.A.B. de C.V. and its
Subsidiaries (collectively the "Company"). While the Company believes that these
management's expectations and forward looking statements are based on reasonable
assumptions, all such statements reflect the current views of the Company with
respect to future events and are subject to certain risks and uncertainties that
could cause actual results to differ materially from those contemplated in this
report. Many factors could cause the actual results, performance or
achievements of the Company to be materially different from any future results,
performance or achievements that may be expressed or implied by such
forward-looking statements, including, among others, changes in general
economic, political, governmental and business conditions worldwide and in such
markets in which the Company does business, changes in interest rates, changes
in inflation rates, changes in exchange rates, the growth or reduction of the
markets and segments where the Company sells its products, changes in raw
material prices,
changes in
energy prices, particularly gas, changes in the business strategy, and other
factors. Should one or more of these risks or uncertainties materialize,
or should the underlying assumptions prove incorrect, actual results may vary
materially from those described herein as anticipated, believed, estimated or
expected. The Company does not assume any obligation, to and will not
update these forward-looking statements. The assumptions, risks and
uncertainties relating to the forward-looking statements in this report include
those described in the Company's annual report in form 20-F file with the U.S.
Securities and Exchange Commission, and in the Company's other filings with the
Mexican Comision Nacional Bancaria y de Valores.
This report on
Form 6-K is incorporated by reference into the Registration Statement on Form
F-4 of Vitro, S.A.B. de C.V. (Registration Number
333-144726).
EFFECTS OF INFLATION
NIF B-10, Effects of
Inflation.- CINIF defines two economic environments: a) inflationary
environment, when cumulative inflation of the three preceding years is 26
percent or more, in which case, the effects of inflation should be recognized
using the comprehensive method; and b) non-inflationary environment, when
cumulative inflation of the three preceding years is less than 26 percent, in
which case, no inflationary effects should be recognized in the financial
statements. Additionally, NIF B-10 eliminates the
replacement cost and specific indexation methods for inventories and fixed
assets, respectively, and requires that the cumulative gain or loss from
holding non-monetary assets be reclassified to retained earnings, if such gain
or loss is realized; the gain or loss that is not realized will be maintained
in stockholders' equity and charged to current earnings of the period in which
the originating item is realized.
INIF 9, Presentation of
Comparative Financial Statements Prepared under NIF B-10.- INIF 9 states that
financial data for year 2008 is presented in nominal pesos while for previous
periods it is expressed in constant pesos as of December 31, 2007.
A body of generally accepted accounting
principles is commonly referred to as "GAAP". A non-GAAP financial measure
is generally defined by the SEC as one that purports to measure historical or
future financial performance, financial position or cash flows but excludes or
includes amounts that would not be so adjusted in the most comparable U.S. GAAP
measure. We disclose in this report certain non-GAAP financial measures,
including EBITDA. EBITDA for any period is defined as consolidated net
income (loss) excluding (i) depreciation and amortization, (ii) non-cash items
related to pension liabilities, (iii) total net comprehensive financing cost
(which is comprised of net interest expense, exchange gain or loss, monetary
position gain or loss and other financing costs and derivative transactions),
(iv) other expenses, net, (v) income tax, (vi) provision for employee retirement
obligations, (vii) cumulative effect of change in accounting principle, net of
tax and (viii) (income) loss from discontinued operations.
In managing our business we rely on EBITDA
as a means of assessing our operating performance and a portion of our
management's compensation and employee profit sharing plan is linked to EBITDA
performance. We believe that EBITDA can be useful to facilitate
comparisons of operating performance between periods and with other companies
because it excludes the effect of (i) depreciation and amortization, which
represents a non-cash charge to earnings, (ii) certain financing costs, which
are significantly affected by external factors, including interest rates,
foreign currency exchange rates and inflation rates, which have little or no
bearing on our operating performance, (iii) income tax and tax on assets and
statutory employee profit sharing, which is similar to a tax on income and (iv)
other expenses or income not related to the operation of the business.
EBITDA is also a useful basis of comparing our results with those of other
companies because it presents operating results on a basis unaffected by capital
structure and taxes.
We also calculate EBITDA in connection
with covenants related to some of our financings. We believe that EBITDA
enhances the understanding of our financial performance and our ability to
satisfy principal and interest obligations with respect to our indebtedness as
well as to fund capital expenditures and working capital requirements.
EBITDA is not a measure of financial performance under U.S. GAAP or Mexican
FRS. EBITDA should not be considered as an alternate measure of net income
or operating income, as determined on a consolidated basis using amounts derived
from statements of operations prepared in accordance with Mexican FRS, as an
indicator of operating performance or as cash flows from operating activity or
as a measure of liquidity. EBITDA has material limitations that impair its
value as a measure of a company's overall profitability since it does not
address certain ongoing costs of our business that could significantly affect
profitability such as financial expenses and income taxes, depreciation, pension
plan reserves or capital expenditures and associated charges. The EBITDA
presented herein relates to Mexican FRS, which we use to prepare our
consolidated financial statements.
Vitro, S.A.B. de C.V. (BMV: VITROA; NYSE: VTO),
is one of the largest glass manufacturers in the world. Through our subsidiary
companies we offer products with the highest quality standards and reliable
services to satisfy the needs of two distinct business sectors: glass containers
and flat glass. Our manufacturing facilities produce, process, distribute and
sell a wide range of glass products that offer excellent solutions to multiple
industries that include: wine, beer, cosmetic, pharmaceutical, food and
beverage, as well as the automotive and construction industry. Also, we supply
raw materials, machinery and industrial equipment to different industries. We
constantly strive to improve the quality of life for our employees as well as
the communities in which we do business by generating employment and economic
prosperity thanks to our permanent focus on quality and continuous improvement
as well as consistent efforts to promote sustainable development. Our World
Headquarters are located in Monterrey, Mexico where Vitro was founded in 1909
and now embarks major facilities and a broad distribution network in ten
countries in the Americas and Europe. Additionally, it exports its products to
over 50 countries around the World. For more information, you can access Vitro's
Website at: http://www.vitro.com.
Conference Call and Web cast
Wednesday, March 4, 2009
11:00 AM U.S. EST - 10:00 A.M. Monterrey
time
A live web cast of the
conference call will be available to investors and the media at
http://www.vitro.com
. A replay of the web cast will be
available through the end of the day on March 11, 2009. For inquiries
regarding the conference call, please contact Danielle Birrer or Susan Borinelli of
Breakstone Group via telephone at (646) 452-2336, or via email at dbirrer
@breakstone-group.com
For further
information, please contact:
Investor Relations
Adrian Meouchi /Angel Estrada
Vitro S.A.B. de C.V.
+ (52) 81-8863-1765 / 1730
ameouchi@vitro.com
aestradag@vitro.com
U.S. Agency
Susan Borinelli / Danielle Birrer
Breakstone Group
(646) 452-2336
sborinelli@breakstone-group.com
bcano@breakstone-group.com
Media Relations
Albert Chico/Roberto Riva
Vitro, S. A. B. de C.V.
+52 (81) 8863-1661/1689
achico@vitro.com
rriva@vitro.com
DETAILED FINANCIAL INFORMATION
FOLLOWS:
Consolidated
Results
Sales
4
EBIT and EBITDA
4
Consolidated Financing Result
5
Taxes
6
Consolidated Net Loss
7
Capital Expenditures
7
Consolidated Financial Position
7
Cash
Flow
9
Derivative Financial Instruments Situation
11
Key
Developments
12
Glass Containers
18
Flat
Glass
19
Consolidated Financial Statements
21
Segmented Information
22
Consolidated Results
Consolidated net sales for 4Q'08
decreased 18.2 percent YoY to US$538 million from US$659 million last year,
mostly affected by a 28.2 percent peso depreciation during the quarter. For
fiscal year 2008, consolidated net sales rose 2.6 percent to US$2,627 million
from US$2,560 million in year 2007. Glass Containers sales for the quarter
decreased YoY by 18.5 percent while Flat Glass sales declined 18.0 percent over
the same time period.
Consolidated EBIT for the quarter decreased 81.5 percent YoY to US$15 million
from US$79 million last year. EBIT margin decreased 9.4 percentage points to 2.7 percent from 12.1 percent. For fiscal year 2008, consolidated EBIT decreased
33.7 percent to US$160 million from US$242 million in year 2007. During this
same period of time, EBIT margin decreased 3.3 percentage points to 6.1 percent
from 9.4 percent.
EBIT for the quarter at Glass Containers decreased by 61.0 percent YoY, while at
Flat Glass EBIT decreased to negative US$6 million from US$20 million in 4Q'07.
Consolidated EBITDA for the quarter decreased
41.8 percent to US$59 million from
US$101 million in 4Q'07. The EBITDA margin declined 4.4 percentage points YoY to
10.9 percent from 15.3 percent due to lower volumes which also impacted fixed-cost
absorption. For fiscal year 2008, consolidated EBITDA declined 15.9 percent to
US$329 million from US$391 million in year 2007. 2008 EBITDA includes US$26
million EBITDA from Comegua for first eleven months of the year. Comegua was
deconsolidated since December 2008.
C
onsolidated
Financial Result
Consolidated financing
result for the quarter increased to US$446 million from US$23 million during
4Q'07. This situation was mainly driven by three factors: a non-cash foreign
exchange loss of US$257 million during 4Q'08 due to a 28.2 percent
depreciation of the Mexican peso compared with a 0.5 percent appreciation in
the same period last year; higher other financing expenses due to the change
in the mark-to-market
1
, which does not represent a cash expense, claimed by
our derivative counterparties; and the elimination of the monetary position
at the beginning of year 2008 due to the new Mexican Financial Reporting
Standards (please refer to the related note on page 2).
For fiscal year 2008,
total consolidated financing result increased to US$752 million from US$147
million mainly driven by higher other financial expenses and lower monetary
position due to the reasons mentioned in the previous paragraph coupled with
a higher non-cash foreign exchange loss due to a 27.3 percent depreciation
during 2008 compared with a 0.5 percent depreciation during year 2007.
1
Please refer to
the Derivative Financial Instruments Situation section
Taxes
Total income tax
decreased from an income of US$16 million in 4Q'07 to an income of US$117
million during this quarter due to lower taxable profits in our Mexican
operations mainly derived from the non-cash change in the mark-to-market
claimed by our derivative counterparties and the depreciation of the Mexican
peso which does not represent a cash outflow.
Consolidated Net Loss
During 4Q'08 the Company recorded a consolidated net
loss of US$343 million compared to a net income of US$48 million during the
same period last year. This variation is mainly the result of a US$423
million increase in total financing result derived from a non-cash change in
the mark-to-market
1
claimed by our derivative counterparties coupled with a
lower EBIT. These factors were partially offset by an income tax gain of
US$117 million during this quarter compared with an income of US$16 million
during the same period last year. During this quarter, other expenses
include US$7 million in severance payments.
Capital expenditures for the quarter totaled US$22
million, compared with US$70 million in 4Q'07. Glass Containers represented 67
percent of total CapEx and was mainly invested in the final stage of the
transfer of Vidriera Mexico's ("Vimex") facilities to Toluca and maintenance.
Flat Glass accounted for 33 percent and was mainly invested in maintenance.
Consolidated Financial Position
The cash deposited as collateral for derivative instruments nets the
derivative instruments liability
1
.
Due the aforementioned, net debt, which is calculated by deducting cash and cash equivalents as well as restricted cash
accounted for in current and other long term assets, increased QoQ by US$25
million to US$1,354 million. On a YoY comparison, net debt increased US$167
million.
As of 4Q'08, the Company had a cash balance of US$110 million, of which US$103 million was recorded
as cash and cash equivalents and US$6 million was classified as other
current assets. The US$6 million is restricted cash collateralizing debt
composed of US$2 million recorded at Flat Glass and US$4 million recorded at
the Holding Company.
Consolidated gross debt as of December 31, 2008 totaled US$1,463 million, a QoQ increase of
US$7 million and a YoY increase of US$91 million.
1
Please refer to the Derivative Financial Instruments
Situation section
The
Company's average life of debt* as of 4Q'08 was 5.5 years compared with 6.9
years for 4Q'07.
Short-term debt* as of December 31, 2008, increased by US$43 million to 9
percent as a percentage of total debt, compared with 6 percent in 4Q'07.
Revolving debt*, included trade-related debt, accounted for 89 percent of
total short-term debt. This type of debt is usually renewed within 28 to 270
days.
Current maturities of long-term debt*, including current maturities of
market debt, decreades by US$36 million to US$14 million from US$50 million
as of December 31 2007. As of 4Q'08 current maturities of long-term debt
represented 11 percent of short-term debt.
As of
December 31 2008 Vitro had an aggregate of US$113 million in off-balance
sheet financing related to sales of receivables and receivable
securitization programs. Flat glass recorded US$63 million and Glass
Containers recorded US$50 million.
Maturities for 2009* include long-term "Certificados Bursatiles" and Credit
Facilities at the Holding Company and subsidiary level.
Maturities for 2009* and thereafter include, among others, long-term
"Certificados Bursatiles", the Senior Notes due in 2012, Senior Notes due in
2013 and Senior Notes due in 2017 at the Holding Company level.
* Does not include the reclassification of the outstanding amount of the Senior
Notes from long-term to short-term
Cash Flow
Cash flow before
CapEx and dividends decreased to US$58 million from US$110 million in 4Q'07.
This was the result of lower EBITDA coupled with the YoY effect of a net
interest expense of US$38 million compared with a net interest income of US$1
million during 4Q'07, which includes a derivative transaction that anticipated
US$50 million. This situation was partially offset by a higher working capital
recovery and lower cash taxes paid.
This cash and flow was used to fund US$22
million in CapEx investments compared with US$70 million in 4Q'07.
Derivative Financial Instruments Situation
Derivative financial
instruments have not been designated as hedges because they do not meet all of
the accounting requirements by the Mexican Financial Reporting Standards and are
therefore classified as trading for accounting purposes.
- Derivative financial instruments for trading purposes:
- Derivative financial instruments unwinded, subject to what is expressed in
the last paragraph of this numeral:
As of December 31, 2008, subject to what is expressed in
the last paragraph of this numeral, certain positions have been unwinded for
approximately US$ 325 million. The cash deposited as collateral related to this
positions accounts approximately US$ 85 million (without including interests).
Some derivative financial instrument counterparties have
filed law suites in the Supreme Court of the State of New York demanding the
payment of the unwinded positions. The Company has been notified of such demands
and has reached stay agreements with counterparties, agreeing a continuance of
the deadline for the filing of its initial response and its defense to such
demands. As to the counterparties that have not filed any claims until this
date, the Company has reached stay agreements for the same period.
*As of December 31, 2008, the Company has hedges for
approximately 70% of its estimated natural gas consumption for 2009, 25% for
2010 and 15% for 2011.
Key Developments
FINANCIAL POSITION
Vitro provides update on financial situation
On February 5, 2009, the Company announced that in order to preserve the necessary
cash to continue its operations and consistent with the Senior Notes interest
payments to bondholders announcement, it elected not to make a scheduled payment
of $150 million pesos, plus accrued interest, due February 5, 2009 on its
Certificados Bursatiles issued in 2003 ("CEBURES 03"). Although the documents
governing the CEBURES 03 grant the Company a 3-day grace period, the Company did
not make the payment in such term; instead Vitro is holding discussions with the
holders of the CEBURES 03 in an effort to reach a mutually acceptable agreement
to restructure this financial obligation along with the rest of the financial
creditors. Vitro also announced that it was informed that Credit Suisse
International (CSIN) has filed a lawsuit against one of its subsidiaries in the
Supreme Court of the State of New York demanding payment of approximately US$85
million. This complaint arises out of a derivative financial instrument (this
amount is part of the US$293 million previously announced) and therefore the
Company is analyzing alternatives. Additionally, the Company informed that an
accounts receivable credit facility with The Royal Bank of Scotland, which
provided funds to one of Vitro's subsidiaries, with a balance of approximately
US$19 million, which was scheduled to end April, 2009, was concluded.
Vitro is continuing its discussions with the counterparties of the derivative financial
instruments ("Counterparties"), its bondholders and its creditors to achieve an
organized financial restructuring to improve its balance sheet. There can be no
assurance that the Company's discussions with the Counterparties, its
bondholders, and other creditors will be successful. Vitro will provide updates
on these discussions, from time to time, as appropriate. Vitro is committed to
providing the quality products and services its broadly diversified customers
need. Vitro intends to maintain its operations and continue its business
relationships with its customers and suppliers as it seeks to achieve a
restructuring of its indebtedness. Vitro, which is commemorating its first
century in 2009, has a strong foundation in place with solid business operations,
strong franchise and market positions and superior quality products.
Vitro provides update on financial situation and cost
reduction initiatives
On January 29, 2009, the Company announced that four of the Counterparties (the
"Counterparties")
with whom the Company and/or its subsidiaries entered into derivative financial
instruments had provided notice to the Company, invoking the agreements
governing the derivative financial instruments (the "DFI Agreements"), stating
that the failure of the Company to pay an aggregate of approximately US$293
million (including approximately US$80 million held as cash collateral by such
Counterparties) constitutes events of default under the DFI Agreements, and have
effectively demanded payment of such amounts. As of December 31st 2008, the
Company had a net loss of approximately US$358 million according to the claims
by its derivative counterparties (not including accrued interest), including a
loss of approximately US$33 million related to the only open derivative
financial instruments covering natural gas contracts from 2009-2011 with Pemex.
The events of default under the DFI Agreements result in an event of default under the indentures
governing the Senior Notes, as described below and the 11.75 percent Senior
Notes due 2013 (the "2013 Notes"), enabling the trustees of such Notes, or with
respect to each of the 2012 Notes, the 2017 Notes, and the 2013 Notes, the
holders of 25 percent or more in principal amount of such Notes, to declare the
US$300 million principal amount (and accrued interest) of the 2012 Notes, the
US$700 million principal amount (and accrued interest) of the 2017 Notes,
respectively and the US$216 million principal outstanding amount (and accrued
interest) of the 2013 Notes, to be immediately due and payable.
The failure of the Company to make the payments due under the DFI Agreements also results in events
of default under various other financing agreements of the Company and its
subsidiaries, aggregating approximately US$81 million and permitting lenders
under such facilities to declare borrowings under these agreements to be
immediately due and payable. In addition, the Company and its subsidiaries are
also in default under loan agreements of approximately US$17 million, and the
Lenders may declare such debt to immediately due and payable. As of December 31,
2008, the Counterparties held an aggregate of approximately US$85 million (not
including accrued interest), as cash collateral for the obligations of the
Company and/or its subsidiaries under the DFI Agreements. In light of these four
Counterparties notices and in order to preserve the necessary cash to continue
operations, the Company does not intend to make scheduled payments due February
2, 2009 of interest of US$12.9 million on its 8.625 percent Senior Notes due
2012 (the "2012 Notes") and US$31.9 million on its 9.125 percent Senior Notes
due 2017 (the "2017 Notes", and together with the 2012 Notes, the "Senior
Notes"). The failure of the Company to make the interest payments within 30 days
after the scheduled payment date would constitute a separate event of default
under the indentures governing the 2012 Notes and the 2017 Notes. Vitro intends
to maintain its operations and continue its business relationships with its
customers and suppliers as it seeks to achieve a restructuring of its
indebtedness. As of December 31, 2008, the Company had unrestricted cash on hand
and cash equivalents of approximately US$103 million, for operating costs and
expenses. As previously disclosed, Vitro has initiated discussions with the
Counterparties, its bondholders and its creditors to achieve an organized
financial restructuring to improve its balance sheet and it continues to analyze
its alternatives in regard with the DFI Agreements. There can be no assurance
that the Company's discussions with the Counterparties, its bondholders, and
other creditors will be successful. Vitro will provide information, from time to
time, as appropriate, about developments of these discussions with the
Counterparties, its bondholders, and its creditors.
The Company has adopted a significant and focused cost reduction plan, which includes reducing the
Company's workforce, canceling airplane leasing contracts, divesture of non
productive assets and eliminating the outsourcing of non-strategic services, as
part of the measures that have been adopted by the Company to improve its
Balance Sheet. It is estimated that these initiatives, as
well as those aimed at reducing operating costs, drastically reducing corporate
expenses and improve efficiency, will represent annual savings between $80 and
US$120 million.
Vitro is confident that it is taking the right steps to
position the Company for the future. Vitro, with almost 100 years of existence,
has a strong foundation in place with solid business operations, strong
franchise and market positions and superior quality products. Vitro sees this as
a temporary measure to allow the necessary time to negotiate with all parties
involved while ensuring it will be able to continue providing the quality
products and services its broadly diversified customers need, and also provide
it with the wherewithal to pay for the materials and services it needs to
manufacture such products. For many of our customers and suppliers these are
trying times as well and Vitro will be there to help them get through with its
continuous operation and production of quality products and services as it has
done in the past.
Vitro strengthens liquidity position
On November 5, 2008, the Company informed the financial community that in order to
improve its liquidity to normal operating levels, it contributed non-productive
real estate assets ("the assets") to a Trust and received an initial payment of
US$100 million from a Development Bank. This structure allowed the Company to
make the assets immediately liquid; restoring its cash position while allowing
enough time to maximize the amount the Company can receive for the assets to be
sold.
AWARDS
Vitro is once again
awarded the distinction of being a Socially Responsible Company for 2009
On March 12, 2009 the Company
announced that its business units Glass Containers and Flat Glass as well as its
subsidiary Clinica Vitro and its Corporate Offices were awarded, for the second
consecutive year, the coveted certification of being a Socially Responsible
Company (ESR 2009) that is awarded by the Mexican Philanthropic Center, A.C. (CEMEFI).
This special distinction was awarded to Vitro in virtue of having met the
established standards in the strategic area of corporate social responsibility
in Mexico. These standards cover the areas of: environment, community, integral
development of its employees and corporate governance.
Clinica Vitro receives the
Ibero-American Quality Award for 2008
On November 3, 2008, the Company received for the fifth occasion the Ibero-American Award for Quality due
to its superior competitive level of quality for its operation of Clinica Vitro. On this occasion the Company received the Silver Award for its outstanding
quality standards after having competed with the most important companies,
organizations and institutions from all of the Spanish speaking countries from
the Americas as well as Spain and Portugal. Since the mid-nineties Vitro has
received: 5 Ibero-American Quality Awards, 6 National Quality Awards and 12
State Quality Awards.
LEGAL
Vitro reached a stay in
the litigation processes with derivative financial counterparties
On March 17, 2009, the Company reached stay agreements with Credit
Suisse, Calyon, Merrill Lynch, Barclays, Deutsche Bank and Citibank, counterparties of
derivative financial instruments. In accordance with these stipulations, the
parties agreed to a continuance of the deadline for the filling of Vitro's
initial responsive pledging in the Supreme Court of the State of New York and a
stay of the litigation processes until April 24, 2009, allowing parties time to
negotiate solutions and reach a satisfactory mutual and final agreements.
Second Collegiate Court
confirms decision of first instance and appeal courts denying Pilkington's
opposition to the merger of Vitro Plan into Vimexico
On February 23, 2009, the Company announced that its subsidiary Vimexico, S.A. de C.V. ("Vimexico"), was notified of the final
non appealable decision issued by the Second Collegiate Court for Civil Affairs
of the Fourth Circuit, ratifying the decision issued by the First Instance and
Appeal Courts denying Pilkington Group Limited's ("Pilkington") opposition to
the resolutions adopted at the Extraordinary Shareholders Meeting held on
December 11, 2006, when the merger of Vitro Plan, S.A. de C.V. ("Vitro Plan")
into Vimexico was approved. As a result of this decision of the Second
Collegiate Court for Civil Affairs of the Fourth Circuit, in accordance with
article 200 of the Mexican General Law of Corporations, it was ratified that all
of the above mentioned resolutions are valid and binding for all shareholders,
including those who voted against such resolutions. In addition, the Collegiate
Court confirmed the dismissal of all claims demanded by Pilkington in its
original complaint and confirmed the validity of the merger of Vitro Plan into
Vimexico approved at the Extraordinary Shareholders Meeting of the now extinct
Vitro Plan. The company was represented by the Mexican law firm Rivera Gaxiola y
Asociados, S.C.
The Collegiate Court confirmed the decision to
condemn Pilkington to pay Vimexico attorneys fees and expenses including those
incurred during the appeals proceedings. Vimexico will timely file an incidental
complaint to liquidate such fees and expenses. The original opinion of counsel
to Vimexico that the company shall also prevail in the separate lawsuit that
Pilkington initiated in October 2007, claiming that the same Extraordinary
Shareholders Meeting was null and void, was likewise reinforced by this final
and non appealable decision.
RATINGS
S&P reaffirms the VENACB 05 certificates' rating and removes it from
CreditWatch
On March 25, 2009 Standard & Poor's ("S&P") reaffirmed the long-term Mexican domestic scale (CaVal) of
'mxAAA' for the VENACB 05 certificates backed by trade receivables generated by
Compania Vidriera, S.A. de C.V. ("Covisa"), Industria del Alcali, S.A. de C.V.
("Alcali") and Comercializadora Alcali ("Comercializadora"), S. de R.L. de C.V. which are three subsidiaries of Vitro Envases Norteamerica S.A. de C.V.("VENA", subsidiary of Vitro S.A.B. de C.V.) and removed the rating from its CreditWatch
list where it had been put on January 30, 2009 with negative outlook. S&P
reaffirmed this rating after it received revised information from Finacity
Corporation, in its role as manager of this transaction, and from Vitro, which
shows an adequate and stable performance of the trade receivables that back the
certificates.
VENACB 05 certificates downgraded by Moody's
On March 20, 2009 Moody's Investors Service ("Moody's") downgraded to Ba1 from Baa1
(Global Scale, Local Currency) and to Aa3.mx from Aaa.mx (Mexican National Scale)
the ratings of VENACB 05 certificates of Covisa, Alcali and Comercializadora
issued in March 2005 by ABN AMRO Bank (Mexico), S.A., Institucion de Banca
Multiple, Division Fiduciaria, acting solely in its capacity as trustee.
Vitro's rating downgraded by Fitch
On February 9, 2009, the Company's Issuer Default Ratings ("IDRs") were downgraded to 'D' from 'C', while the national scale long-term
rating and the Certificados Bursatiles issuances were downgraded to 'D(mex)'
from 'C(mex)' by Fitch Ratings ("Fitch"). In addition, Fitch has affirmed the
following ratings:
FINANCIAL HIGHLIGHTS*
4Q'08
4Q'07
% Change
Consolidated Net Sales
538
659
-18.2%
Glass Containers
275
337
-18.5%
Flat Glass
256
312
-18.0%
Cost of Sales
392
436
-10.1%
Gross Income
146
223
-34.3%
Gross Margins
27.2%
33.8%
-6.6 pp
SG&A
132
143
-8.1%
SG&A % of sales
24.5%
21.8%
2.7 pp
EBIT
15
79
-81.5%
EBIT Margins
2.7%
12.1%
-9.4 pp
EBITDA
59
101
-41.8%
Glass Containers
50
76
-34.2%
Flat Glass
7
30
-75.9%
EBITDA Margins
10.9%
15.3%
-4.4 pp
Net Income
(343)
48
-
Net Income Margins
-63.6%
7.2%
-71 pp
Total Debt
1,463
1,373
6.6%
Short Term Debt
1,337
87
1440.1%
Long Term Debt
127
1,286
-90.1%
Average life of debt
(1)
5.5
6.9
Cash & Cash Equivalents
(2)
110
186
-41.2%
Total Net Debt
1,354
1,186
14.1%
* Million US$ Nominal
(1) 4Q'08 average
life of debt does not reflect the reclassification of the
outstanding amount
of the Senior Notes debt from long-term to short-term.
(2) In 2007, Cash & Cash Equivalents include restricted cash which
corresponded to cash collateralizing debt and derivatives instruments accounted for in other current
assets while in 2008 they include cash collaterizing debt also
accounted for in other current assets. Please refer to the
Consolidated Financial Position section.
Dec-08
Dec-07
Inflation in Mexico
Quarter
2.5%
1.5%
Accumulated
6.5%
3.8%
Inflation in USA
Quarter
-4.8%
0.7%
Accumulated
0.3%
4.1%
Exchange Rate
Closing
13.8325
10.8662
Devaluation
Quarter
28.2%
-0.5%
Accumulated
27.3%
0.5%
Fourth
Quarter 2008 results
Sales
Table 1: Total Sales
Table 1
Sales
(Million)
YoY%
YoY%
4Q'08
4Q'07
Change
2008
2007
Change
Pesos
(1)
Total Consolidated Sales
7,147
7,190
(0.6)
29,013
28,591
1.5
Glass Containers
3,646
3,672
(0.7)
15,484
14,639
5.8
Flat Glass
3,395
3,418
(0.7)
13,187
13,591
(3.0)
Domestic Sales
3,444
3,019
14.1
12,831
12,008
6.9
Export Sales
1,337
1,621
(17.5)
6,547
6,673
(1.9)
Foreign Subsidiaries
2,367
2,550
(7.2)
9,635
9,911
(2.8)
Nominal Dollars
Total Consolidated Sales
538
659
(18.2)
2,627
2,560
2.6
Glass Containers
275
337
(18.5)
1,406
1,317
6.8
Flat Glass
256
312
(18.0)
1,191
1,210
(1.6)
Domestic Sales
241
278
(13.2)
1,157
1,078
7.4
Export Sales
112
149
(24.4)
600
601
(0.3)
Foreign Subsidiaries
185
232
(20.3)
870
881
(1.2)
% Foreign Currency Sales* / Total Sales
55%
58%
-2.6 pp
56%
58%
-1.9 pp
% Export Sales / Total Sales
21%
23%
-1.7 pp
23%
23%
-0.7 pp
(1) Financial data for year 2008 is presented in nominal pesos while
for previous periods it is expressed in constant pesos as of December
31, 2007. For more details please refer to the note regarding new Mexican
Financial Reporting Standards on page 2.
* Exports + Foreign Subsidiaries
EBIT and EBITDA
Table 2: EBIT and EBITDA
Table 2
EBIT and EBITDA
(Million)
YoY%
YoY%
4Q'08
4Q'07
Change
2008
2007
Change
Pesos
(1)
Consolidated EBIT
187
867
(78.4)
1,710
2,704
(36.7)
Margin
2.6%
12.1%
-9.5 pp
5.9%
9.5%
-3.6 pp
Glass Containers
330
705
(53.2)
1,661
2,085
(20.3)
Flat Glass
(89)
218
--
186
782
(76.3)
Consolidated EBITDA
772
1,100
(29.8)
3,605
4,379
(17.7)
Margin
10.8%
15.3%
-4.5 pp
12.4%
15.3%
-2.9 pp
Glass Containers
660
828
(20.3)
2,776
3,100
(10.5)
Flat Glass
90
331
(72.7)
789
1,320
(40.3)
Nominal Dollars
Consolidated EBIT
15
79
(81.5)
160
242
(33.7)
Margin
2.7%
12.1%
-9.4 pp
6.1%
9.4%
-3.3 pp
Glass Containers
25
65
(61.0)
152
188
(18.7)
Flat Glass
(6)
20
--
20
69
(70.7)
Consolidated EBITDA
59
101
(41.8)
329
391
(15.9)
Margin
10.9%
15.3%
-4.4 pp
12.5%
15.3%
-2.8 pp
Glass Containers
50
76
(34.2)
252
278
(9.4)
Flat Glass
7
30
(75.9)
74
116
(36.5)
(1) Financial data for year 2008 is presented in nominal
pesos while for previous periods it is expressed in constant pesos as of December 31, 2007. For more details please refer to the note
regarding new Mexican Financial Reporting Standards on
page 2.
Table 3: Total Financing Result
Table 3
Total Financing Result
(Million)
YoY%
YoY%
4Q'08
4Q'07
Change
2008
2007
Change
Pesos
(1)
Interest Expense
(544)
(390)
39.5
(1,691)
(1,703)
(0.7)
Interest Income
16
10
57.8
58
175
(67.0)
Other Financial Expenses
(2)
(1,957)
(45)
4,209.7
(4,222)
(509)
729.0
Foreign Exchange (Loss)
(3,367)
(2)
--
(3,221)
(94)
--
Monetary Position (Loss)
(3)
-
175
--
-
471
--
Total Financing Result
(5,852)
(253)
2,216.1
(9,076)
(1,660)
446.8
Nominal Dollars
Interest Expense
(41)
(36)
14.2
(151)
(152)
(1.0)
Interest Income
1
1
29.9
5
16
(66.6)
Other Financial Expenses
(2)
(149)
(4)
3,495.1
(367)
(46)
704.5
Foreign Exchange (Loss)
(257)
0
--
(240)
(7)
--
Monetary Position (Loss)
(3)
-
16
--
-
42
--
Total Financing Result
(446)
(23)
1,854.6
(752)
(147)
412.6
(1) Financial data for year 2008 is presented in nominal pesos while
for previous periods it is expressed in constant pesos as of December
31, 2007. For more details please refer to the note regarding new Mexican Financial
Reporting Standards on page 2.
(2) Includes derivative transactions and interest related to factoring
transactions
(3) According with the new Mexican Financial Reporting Standards, the
monetary position effect was eliminated at the beginning of year 2008.
For further details please refer to the note regarding new Mexican Financial
Reporting Standards on page 2.
Table 4: Taxes
Table 4
Taxes
(Million)
YoY%
YoY%
4Q'08
4Q'07
Change
2008
2007
Change
Pesos
(1)
Accrued Income Tax
20
253
(91.9)
132
395
(66.6)
Deferred Income Tax (gain)
(1,602)
(422)
279.6
(2,271)
(351)
546.4
Total Income Tax
(1,582)
(169)
836.9
(2,139)
44
--
Nominal Dollars
Accrued Income Tax
1
23
(94.2)
12
36
(66.1)
Deferred Income Tax (gain)
(119)
(39)
204.9
(181)
(32)
461.1
Total Income Tax
(117)
(16)
648.8
(169)
3
--
(1) Financial data for year 2008 is presented in nominal pesos
while for previous periods it is expressed in constant pesos as of
December 31, 2007. For more details please refer to the note regarding new Mexican
Financial Reporting Standards on page 2.
Capital Expenditures
(CapEx)
Table 5
Debt Indicators
(Million dollars; except as indicated)
4Q'08
3Q'08
2Q'08
1Q'08
4Q'07
Interest Coverage
(1)
(EBITDA/ Interest Expense)
(Times) LTM
2.1
2.6
2.6
2.6
2.6
Leverage
(1)
(Total Debt / EBITDA)
(Times) LTM
5.6
4.0
3.8
3.6
3.4
(Total Net Debt / EBITDA)
(Times) LTM
5.2
3.6
3.6
3.3
2.9
Total Debt
(2)
1,463
1,456
1,426
1,402
1,373
Short-Term Debt
(3)
1,337
158
143
132
87
Long-Term Debt
127
1,299
1,283
1,270
1,286
Cash and Equivalents
(4)
110
128
77
138
186
Total Net Debt
1,354
1,329
1,349
1,264
1,186
Currency Mix (%) dlls&Euros/Pesos
96/4
95/5
97/3
98/2
98/2
(1) Financial ratios are calculated using figures in pesos
(2) Beginning in 4Q'08, total debt does not include US$74 million
corresponding to the debt of Comegua, which was deconsolidated
starting December 1st, 2008.
(3) Since we are not in full compliance under our bond indentures,
the outstanding amount of the Senior Notes debt was reclassified
from long-term to short-term
(4) Cash & Cash Equivalents include restricted cash
which corresponded to cash collateralizing debt and derivative
instruments accounted for in current and other long
term assets.
Table 6: Cash Flow Analysis
Table 6
Cash Flow from Operations Analysis
(1)
(Million)
YoY%
YoY%
4Q'08
4Q'07
Change
2008
2007
Change
Pesos
(2)
EBITDA
772
1,100
(29.8)
3,605
4,379
(17.7)
Net Interest Expense
(3)
(521)
14
--
(1,934)
(1,213)
59.5
Working Capital
(4)
559
309
81.0
(288)
31
--
Cash Taxes (paid) recovered
(5)
(62)
(189)
(67.3)
(277)
(530)
(47.8)
Cash Flow before Capex and Dividends
749
1,233
(39.3)
1,107
2,667
(58.5)
Capex
(290)
(767)
(62.2)
(1,909)
(2,695)
(29.2)
Dividends
3
(2)
--
(271)
(207)
30.5
Net Free Cash Flow
461
464
(0.5)
(1,073)
(235)
356.5
Nominal Dollars
EBITDA
59
101
(41.8)
329
391
(15.9)
Net Interest Expense
(3)
(38)
1
--
(173)
(108)
60.3
Working Capital
(4)
42
26
59.8
(37)
3
--
Cash Taxes (paid) recovered
(5)
(4)
(17)
(74.5)
(24)
(48)
(48.8)
Cash Flow before Capex and Dividends
58
110
(47.2)
94
238
(60.3)
Capex
(22)
(70)
(69.1)
(176)
(242)
(27.3)
Dividends
0
(0)
--
(26)
(19)
37.7
Net Free Cash Flow
37
40
(7.8)
(107)
(23)
376.6
(1) This statement is a Cash Flow statement and it does not represent a
Statement of Cash Flow according with Mexican FRS
(2) Financial data for year 2008 is presented in nominal pesos while
for previous periods it is expressed in constant pesos as of December
31, 2007. For more details please refer
to the note regarding new Mexican Financial Reporting Standards
on page 2.
(3) Year 2007 does not include additional interests and transaction fees
associated with the debt refinancing completed in 1Q'07.
(4) Includes: Clients, inventories, suppliers, other current assets and
liabilities, IVA (Value Added Tax) and ISCAS taxes (Salary Special Tax)
(5) Includes PSW (Profit Sharing to Workers)
Open Derivative financial instruments
Notional MMBTUs
Period
Fair Value Asset (Liability), (million pesos)
Swaps and Options of natural gas with Pemex
23,220,000*
2009 to 2011*
(433)
Embedded derivatives identified in supply contracts
(20)
Total derivative financial instruments
(453)
Derivative financial instruments unwinded
Unwinded Positions Value (million pesos)
Natural Gas
(2,992)
Forreign exchange
(1,648)
Interest rate
197
Total derivative financial instruments unwinded
(4,443)
Cash deposited as collateral
1,177
Total derivative financial instruments unwinded, net
(3,266)
US$225 million senior notes due 2013 at 'CC/RR4';
US$700 million senior notes due 2017 at 'CC/RR4'.
According to Fitch, the rating downgrades followed Vitro's announcement that it was not going to make the payment of the Certificados Bursatiles 'VITRO 03' for approximately $150 million pesos plus accrued interest. The 'CC/RR4' rating on Vitro's Sr. notes reflects average recovery prospects given default.
Vitro's rating downgraded by Standard & Poor's
On February 2, 2009, the Company's global scale ratings, including the long-term corporate credit rating, were downgraded to 'D' from 'CC' by S&P. At the same time, S&P lowered the Company's long-term Mexican national scale (CaVal) rating to 'mxD' from 'mxCCC'. The recovery rating on the notes remains at '3'. According to S&P, the downgrade is based on Vitro's failure to pay its coupon payments due Feb. 2. Although the notes allow a 30-day grace period, the Company has indicated that it does not intend to make scheduled payments of interest of US$12.9 million on its 8.625 percent senior notes due 2012 and US$31.9 million on its 9.125 percent senior notes due 2017. Vitro is Mexico's leading producer of glass containers and has a significant share of the Mexican flat-glass market. Vitro's export activities and international operations contribute to about 58 percent of total revenues.
Vitro's rating downgraded by Moody's
On January 26, 2009, the Company's unsecured debt and corporate family ratings were downgraded to Ca from Caa1 by Moody's. This rating action concludes the rating review initiated on October 30, 2008. The ratings outlook is negative. The downgrade reflects Moody's belief that Vitro's liquidity has continued to weaken in the past several weeks as economic conditions in the company's key markets have deteriorated further, increasing the likelihood that it may not be able to meet its upcoming near term financial obligations. The latter include a US$45 million coupon payment on February 1, 2009 under its 2012 and 2017 notes and an estimated US$20 million in long term debt maturities during 1Q09. The company also has a contractual commitment to pay about US$29 million in remaining ten monthly installments during 2009, related to the put option exercised by its Spanish joint venture partner in 2008.
The Ca rating reflects the Moody's expectation of modest recovery for the senior unsecured debt class in the case of default. The negative outlook reflects the risk that ultimate recovery level may be lower than currently expected. The last rating action on Vitro was on October 30, 2008, when Moody's downgraded the company's ratings to Caa1 from B2 and left the ratings on review for further downgrade.
ORGANIZATIONAL CHANGES
Vitro's new executive team
On November 18, 2008, the Company announced the new executive team reporting to Hugo Lara, Vitro's CEO. Roberto Rubio, who was the President of Diverse Industries and Central Technology, was designated as President of the Flat Glass business unit, formerly in charge of Hugo Lara. Roberto's previous experience as head of such business unit will be a key issue for its future performance. The Technology function will be integrated to Vitro's Flat Glass and Glass Containers businesses units. Enrique Osorio, former Chief Financial Officer, decided to retire from the Company. The Finance and Administrative areas were merged and are in charge of Claudio Del Valle. David Gonzalez continues as Glass Containers President and Alejandro Sanchez Mujica as President Legal and General Counsel.
The Board of Directors designated Hugo Lara as Vitro's Chief Executive Officer
On November 14, 2008, the Company announced that it was taking the necessary measures in order to embrace the current worldwide financial situation and with this purpose, the Board of Directors decided to provide a professional approach to the Company's management by integrating an independent executive, designating Hugo Lara as the new CEO of Vitro. Federico Sada, former CEO will continue as a member of the Board of Directors.
Before working at Vitro, Hugo Lara led Parmalat in Mexico as its CEO. During his more than five years career in the Company, he has been in charge of several executive positions and was former Flat Glass business unit President. Hugo Lara stated that he will immediately focus on a cost and expenses reduction program, as well as to an organizational restructuring process in order to strengthen Vitro's financial position and liquidity. At the same time, he commented that each of the Company's business unit's plans will be reviewed to assure its viability through the challenging financial environment we are facing. The Board of Directors pointed out that it will closely follow each and every one of the actions implemented in the future by the Company to assure it continues creating value for its customers, shareholders, suppliers, investors, employees, financial institutions and other key audiences.
OTHER
Vitro and its Joint Venture partners agree on extended payment period for purchase of Vitro Cristalglass shares
On January 9, 2009, the Company announced that its subsidiary Vimexico, S.A. de C.V. in conjunction with the Prado Family members and Invergar Participaciones Inmobiliarias, S.L., the joint venture partners in its Spanish subsidiary Vitro Cristalglass, S.L. ("Vitro Cristalglass"), agreed to extend the distribution of payment for the purchase by Vimexico of its joint venture partners' 40 percent stake in Vitro Cristalglass through the remainder of 2009. During the third quarter of 2008, Vimexico made a partial payment to its joint venture partners of approximately 4 million Euros. The agreement to extend the payment period for its joint venture partners' interest in Vitro Cristalglass is consistent with a number of actions Vitro has undertaken to strengthen its balance sheet and enhance liquidity.
Vitro receives notice of fewer glass containers orders from Grupo Modelo
On December 18, 2008, the Company announced that Grupo Modelo ("Modelo"), one of its key customers in the Glass Container business unit, notified Vitro that, due to the current world market contraction, it reduced its beer bottles requirements. Both companies continue conversations in order to find common solutions that minimize the impact of this volume decrease. Several alternatives are being analyzed including giving Vitro the priority on Modelo's new product developments as well as anticipating 2009 shipments to ensure Vitro's production programs continuity. Vitro and Modelo have worked together for over 40 years in a mutually beneficial business relationship that has allowed both companies to achieve a significant growth in sales and profits. The volume reduction impact in Vitro's annual consolidated sales figures for 2009, will be of approximately 6.9 percent of 2008 estimated sales. In anticipation of this volume reduction, the Glass Container business unit will optimize its production capacity in order to maximize utilization and efficiencies of its manufacturing facilities to support its existing business base as well as taking advantage of new business opportunities.
Vitro strengthens its growing glass containers business in Central America and the Caribbean Markets
On December 10, 2008, the Company announced that together with its two Central American partners, they decided to share the control of the daily operations of Panama-based Empresas Comegua, S.A. ("Comegua"). This decision is intended to further drive glass containers business growth in the Central American and Caribbean markets. Vitro will maintain its 49.7 percent interest in Comegua, whose operations will continue to be benefited with the indubitable contributions and knowledge of all of its partners in glass containers manufacturing and market penetration. As a result of this decision, Vitro now accounts its 49.7 percent participation in Comegua under the equity method, therefore, majority stockholders' equity and majority net income are not affected. Vitro and its partners London Overseas, Inc. and Golden Beer, Inc. have participated in the Comegua joint venture since 1964. Comegua is by far the most important glass containers manufacturer in the region, and maintains a strong market presence in Central America and the Caribbean. Comegua last twelve months 3Q'08 sales and EBITDA were approximately US$216 MM and US$32 MM, respectively.
Vitro launches in Europe its new line of self cleaning glass ECOPURE
On January 23, 2009, the Company announced the launching of its new product line ECOPURE, its new self cleaning glass, through its European affiliate Vitro Cristalglass. ECOPURE is a glass called hydrophobic that is very resistant and colorless which substantially improves visibility during and after it rains. Its exclusive coating destroys organic contaminants on its surface and increases the sliding action of the water over the glass thus allowing for easy elimination of dirt and reduces considerably the frequency of manual window washing. ECOPURE is a glass that can be combined with other products from the product selection of Vitro Cristalglass as the treatment is applied on just one face of the glass surface.
Inauguration of Telefonica's new City of Communications, the largest corporate project in Europe
On October 8, 2008, the new corporate home of Telefonica, District C, was officially inaugurated. Telefonica's new City of Communications, with its 140,000 square meters of glazed surfaces in the facades, is now the largest urban development in terms of glass ever carried out in Spain and in Europe. For this project, Vitro Cristalglass specifically designed SUPERDUAL-T, a product that enables substantial energy savings due to its optimal solar factor. In addition, Vitro Cristalglass supplied MULTIPACT over extra-clear glass and SOLARLUX Supernatural 70/40.
Glass Containers
(54 percent of 2008 Consolidated Sales)
Sales for the quarter decreased 18.5 percent YoY to US$275 million from US$337 million.
The main drivers behind the 16.9 percent YoY decrease in domestic sales were a 28.2 percent depreciation of the Mexican peso during the quarter coupled with lower volumes across all segments due to the effect of the complicated economic environment on demand.
Export sales decreased 14.1 percent due to lower volumes in almost every segment which were partially offset by an improved price mix in the soft drinks, food and wine & liquor markets.
Sales from Glass Containers' foreign subsidiaries decreased 30.7 percent YoY due to the deconsolidation of Comegua, our subsidiary in Central and South America, starting December 1 st 2008.
EBIT for the quarter decreased 61.0 percent YoY to US$25 million from US$65 million in 4Q'07. EBITDA for the same period decreased 34.2 percent to US$50 million from US$76 million. On a comparable basis, excluding Comegua which was deconsolidated since December 2008, EBITDA would have decreased 30.7 percent YoY.
During this quarter, EBIT and EBITDA were affected by lower volumes (lower fixed-cost absorption) which were partially offset by better efficiencies in the new CFT plant in Toluca, Vitro Cosmos ("Cosmos"), and cost-reduction projects.
EBITDA from Mexican glass containers operations, which is Glass Container's core business and represents approximately 77 percent of total EBITDA, decreased 37 percent YoY due to the above mentioned factor.
Table 7: Glass Containers | ||||||
Table 7 | ||||||
Glass Containers | ||||||
(Million) | ||||||
YoY% | YoY% | |||||
4Q'08 | 4Q'07 | Change | 2008 | 2007 | Change | |
Pesos (1) | ||||||
Consolidated Net sales | 3,646 | 3,672 | (0.7) | 15,484 | 14,639 | 5.8 |
Net Sales | ||||||
Domestic Sales | 2,337 | 2,059 | 13.5 | 9,028 | 8,372 | 7.8 |
Exports | 870 | 979 | (11.1) | 4,179 | 4,027 | 3.8 |
Foreign Subsidiaries | 439 | 634 | (30.8) | 2,276 | 2,240 | 1.6 |
EBIT | 330 | 705 | (53.2) | 1,661 | 2,085 | (20.3) |
EBITDA | 660 | 828 | (20.3) | 2,776 | 3,100 | (10.5) |
EBIT Margin | 9.1% | 19.2% | -10.1 pp | 10.7% | 14.2% | -3.5 pp |
EBITDA Margin | 18.1% | 22.5% | -4.4 pp | 17.9% | 21.2% | -3.3 pp |
Nominal Dollars | ||||||
Consolidated Net sales | 275 | 337 | (18.5) | 1,406 | 1,317 | 6.8 |
Domestic Sales | 157 | 189 | (16.9) | 814 | 749 | 8.6 |
Export Sales | 77 | 90 | (14.1) | 383 | 365 | 5.1 |
Foreign Subsidiaries | 40 | 58 | (30.7) | 209 | 203 | 3.0 |
EBIT | 25 | 65 | (61.0) | 152 | 188 | (18.7) |
EBITDA | 50 | 76 | (34.2) | 252 | 278 | (9.4) |
EBIT Margin | 9.2% | 19.2% | -10 pp | 10.8% | 14.2% | -3.4 pp |
EBITDA Margin | 18.2% | 22.6% | -4.4 pp | 17.9% | 21.1% | -3.2 pp |
Glass Containers | ||||||
Domestic (Millions of Units) | 959 | 1,206 | (20.5) | 4,704 | 4,841 | (2.8) |
Exports (Millions of Units) | 295 | 356 | (17.2) | 1,351 | 1,347 | 0.3 |
Total | 1,254 | 1,562 | (19.7) | 6,055 | 6,187 | (2.1) |
Installed capacity utilization (furnaces) | 72% | 94% | -22 pp | |||
Alcali (Thousands Tons sold)* | 162 | 163 | (0.8) | 659 | 636 | 3.6 |
(1) Financial data for year 2008 is presented in nominal pesos while
for previous periods it is expressed in constant pesos as of December
31, 2007.
For more details please refer to the note regarding new Mexican Financial Reporting Standards on page 2. |
||||||
* Includes sodium carbonate, sodium bicarbonate, sodium chlorine, calcium chlorine |
Flat Glass
(45 percent of 2008 Consolidated Sales)
Sales
Flat Glass sales for the quarter decreased 18.0 percent YoY to US$256 million from US$312 million.
Domestic sales decreased 4.3 percent YoY mainly as result of lower volumes in the automotive business line and in the float glass market coupled with the effect on prices of the Mexican peso depreciation during the quarter.
Export sales decreased 40.2 percent YoY due to lower volumes in the automotive business line. This situation was partially offset by higher float glass volumes sold to South and Central American markets.
Automotive sales declined 23 percent YoY driven by lower sales in the OEM business line, the exchange rate effect on the prices of the domestic Auto Glass Replacement ("AGR") market, and lower export AGR sales as we continue to focus on the domestic replacement market. These factors were partially offset by a 5 percent volume increase YoY in the domestic AGR market during 4Q'08.
Sales from foreign subsidiaries decreased 16.8 percent YoY to US$145 million from US$174 million as a result of weakening markets and softening demand.EBIT & EBITDA
EBIT for the quarter decreased YoY to negative US$6 million from US$20 million while EBITDA decreased 75.9 percent YoY to US$7 million from US$30 million. During the same period, EBIT and EBITDA margins decreased 8.8 and 6.9 percentage points respectively.
On a YoY comparison, lower volumes (with the consequent lower fixed-cost absorption) derived from sluggish construction and automotive markets had a negative impact on EBIT and EBITDA.
Table 8: Flat Glass | ||||||
Table 8 | ||||||
Flat Glass | ||||||
(Million) | ||||||
YoY% | YoY% | |||||
4Q'08 | 4Q'07 | Change | 2008 | 2007 | Change | |
Pesos (1) | ||||||
Consolidated Net sales | 3,395 | 3,418 | (0.7) | 13,187 | 13,591 | (3.0) |
Net Sales | ||||||
Domestic Sales | 1,001 | 861 | 16.3 | 3,461 | 3,274 | 5.7 |
Exports | 467 | 642 | (27.3) | 2,368 | 2,646 | (10.5) |
Foreign Subsidiaries | 1,928 | 1,916 | 0.6 | 7,358 | 7,671 | (4.1) |
EBIT | (89) | 218 | -- | 186 | 782 | (76.3) |
EBITDA | 90 | 331 | (72.7) | 789 | 1,320 | (40.3) |
EBIT Margin | -2.6% | 6.4% | -9 pp | 1.4% | 5.8% | -4.4 pp |
EBITDA Margin | 2.7% | 9.7% | -7 pp | 6.0% | 9.7% | -3.7 pp |
Nominal Dollars | ||||||
Consolidated Net sales | 256 | 312 | (18.0) | 1,191 | 1,210 | (1.6) |
Domestic Sales | 76 | 80 | (4.3) | 313 | 296 | 5.9 |
Export Sales | 35 | 59 | (40.2) | 217 | 237 | (8.6) |
Foreign Subsidiaries | 145 | 174 | (16.8) | 661 | 677 | (2.4) |
EBIT | (6) | 20 | -- | 20 | 69 | (70.7) |
EBITDA | 7 | 30 | (75.9) | 74 | 116 | (36.5) |
EBIT Margin | -2.4% | 6.4% | -8.8 pp | 1.7% | 5.8% | -4.1 pp |
EBITDA Margin | 2.8% | 9.7% | -6.9 pp | 6.2% | 9.7% | -3.5 pp |
Volumes | ||||||
Flat Glass (Thousands of m2R) (2),(3) | 31,816 | 33,871 | (6.1) | 133,089 | 132,790 | 0.2 |
Capacity utilization | ||||||
Float Glass furnaces (4) | 109% | 110% | -1.2 pp | |||
Flat Glass auto | 70% | 76% | -6.1 pp | |||
(1) Financial data for year 2008 is presented in nominal pesos while
for previous periods it is expressed in constant pesos as of December
31, 2007.
For more details please refer to the note regarding new Mexican Financial Reporting Standards on page 2. |
||||||
(2) Flat Glass volumes only include float and automotive glass manufactured at our Mexican subsidiaries | ||||||
(3) m2R = Reduced Squared Meters | ||||||
(4) Capacity utilization may sometimes be greater than 100 percent because pulling capacity is calculated based on a certain number of changes in glass color & thickness, determined by historical averages. | ||||||
CONSOLIDATED | |||||||||||||||||
VITRO, S.A.B. DE C.V. AND SUBSIDIARIES | |||||||||||||||||
CONSOLIDATED FINANCIAL STATEMENTS | |||||||||||||||||
FOR THE PERIODS, (MILLION) | |||||||||||||||||
Fourth Quarter | January - December | ||||||||||||||||
INCOME STATEMENT | Pesos (1) | Nominal Dollars | Constant Pesos | Nominal Dollars | |||||||||||||
2008 | 2007 | % Var. | 2008 | 2007 | % Var. | 2008 | 2007 | % Var. | 2008 | 2007 | % Var. | ||||||
Consolidated Net Sales | 7,147 | 7,190 | (0.6) | 538 | 659 | (18.2) | 29,013 | 28,591 | 1.5 | 2,627 | 2,560 | 2.6 | |||||
Cost of Sales | 5,212 | 4,763 | 9.4 | 392 | 436 | (10.1) | 21,279 | 20,188 | 5.4 | 1,927 | 1,807 | 6.7 | |||||
Gross Income | 1,935 | 2,427 | (20.2) | 146 | 223 | (34.3) | 7,735 | 8,404 | (8.0) | 701 | 753 | (7.0) | |||||
SG&A Expenses | 1,748 | 1,560 | 12.1 | 132 | 143 | (8.1) | 6,024 | 5,700 | 5.7 | 540 | 512 | 5.6 | |||||
Operating Income | 187 | 867 | (78.4) | 15 | 79 | (81.5) | 1,710 | 2,704 | (36.7) | 160 | 242 | (33.7) | |||||
-- | -- | ||||||||||||||||
Other Expenses (Income), net | 398 | 268 | 48.5 | 29 | 25 | 17.9 | 495 | 869 | (43.0) | 38 | 77 | (50.5) | |||||
Share in earnings of unconsolidated associated companies | 5 | - | -- | 0 | - | -- | 5 | - | -- | 0 | - | -- | |||||
-- | -- | #DIV/0! | |||||||||||||||
Interest Expense | (544) | (390) | 39.5 | (41) | (36) | 14.2 | (1,691) | (1,703) | 0.7 | (151) | (152) | 1.0 | |||||
Interest Income | 16 | 10 | 57.8 | 1 | 1 | 29.9 | 58 | 175 | (67.0) | 5 | 16 | (66.6) | |||||
Other Financial Expenses (net)* | (1,957) | (45) | -- | (149) | (4) | -- | (4,222) | (509) | (729.0) | (367) | (46) | (704.5) | |||||
Exchange Loss | (3,367) | (2) | -- | (257) | 0 | -- | (3,221) | (94) | -- | (240) | (7) | -- | |||||
Gain from Monet. Position | - | 175 | -- | - | 16 | -- | - | 471 | -- | - | 42 | -- | |||||
Total Financing Result | (5,852) | (253) | -- | (446) | (23) | -- | (9,076) | (1,660) | (446.8) | (752) | (147) | (412.6) | |||||
Inc. (loss) bef. Tax | (6,057) | 346 | -- | (460) | 32 | -- | (7,857) | 174 | -- | (630) | 18 | -- | |||||
Income Tax | (1,582) | (169) | (836.9) | (117) | (16) | (648.8) | (2,139) | 44 | -- | (169) | 3 | -- | |||||
Net Inc. (loss) Cont. Opns. | (4,475) | 515 | -- | (343) | 48 | -- | (5,718) | 131 | -- | (461) | 14 | -- | |||||
Income (loss)of Discont. Oper. | - | - | -- | - | - | -- | - | - | -- | - | - | -- | |||||
Income on disposal of discontinued operations | - | - | -- | - | - | -- | - | - | -- | - | - | -- | |||||
Extraordinary Items, Net | - | - | -- | - | - | -- | - | - | -- | - | - | -- | |||||
Net Income (Loss) | (4,475) | 515 | -- | (343) | 48 | -- | (5,718) | 131 | -- | (461) | 14 | -- | |||||
Net Income (loss) of Maj. Int. | (4,419) | 476 | -- | (338) | 44 | -- | (5,659) | (13) | -- | (456) | 2 | -- | |||||
Net Income (loss) of Min. Int. | (56) | 39 | -- | (5) | 4 | -- | (58) | 143 | -- | (5) | 12 | -- | |||||
VITRO, S.A.B. DE C.V. AND SUBSIDIARIES | ||||||||||||||||||
CONSOLIDATED FINANCIAL STATEMENTS | ||||||||||||||||||
As of December 31, (Million) | ||||||||||||||||||
Pesos (1) | Nominal Dollars | |||||||||||||||||
BALANCE SHEET | 2008 | 2007 | % Var. | 2008 | 2007 | % Var. | FINANCIAL INDICATORS (2) | 4Q'08 | 4Q'07 | |||||||||
Cash & Cash Equivalents | 1,430 | 1,638 | (12.7) | 103 | 151 | (31.4) | Debt/EBITDA (LTM, times) | 5.6 | 3.4 | |||||||||
Trade Receivables | 1,457 | 1,629 | (10.5) | 105 | 150 | (29.7) | EBITDA/ Interest. Exp. (LTM, times) | 2.1 | 2.6 | |||||||||
Inventories | 4,178 | 4,120 | 1.4 | 302 | 379 | (20.3) | Debt / (Debt + Equity) (times) | 0.9 | 0.6 | |||||||||
Other Current Assets | 3,033 | 3,749 | (19.1) | 219 | 345 | (36.5) | Debt/Equity (times) | 6.2 | 1.6 | |||||||||
Total Current Assets | 10,098 | 11,136 | (9.3) | 730 | 1,025 | (28.8) | Total Liab./Stockh. Equity (times) | 9.4 | 2.4 | |||||||||
Curr. Assets/Curr. Liab. (times) | 0.4 | 1.6 | ||||||||||||||||
Prop., Plant & Equipment | 17,272 | 17,842 | (3.2) | 1,249 | 1,642 | (24.0) | Sales/Assets (times) | 0.9 | 0.9 | |||||||||
Deferred Assets | 5,599 | 3,069 | 82.4 | 405 | 282 | 43.3 | EPS (Ps$) * | (12.33) | 1.33 | |||||||||
Other Long-Term Assets | 92 | 141 | (34.7) | 7 | 13 | (48.7) | EPADR (US$) * | (2.83) | 0.37 | |||||||||
Investment in Affiliates (3) | 996 | - | -- | 72 | - | -- | ||||||||||||
Total Assets | 34,057 | 32,188 | 5.8 | 2,462 | 2,962 | (16.9) | ||||||||||||
* Based on the weighted average shares outstanding. | ||||||||||||||||||
Short-Term & Curr. Debt (4) | 18,488 | 943 | 1,860.5 | 1,337 | 87 | 1,440.1 | OTHER DATA | |||||||||||
Trade Payables | 2,355 | 2,462 | (4.3) | 170 | 227 | (24.8) | # Shares Issued (thousands) | 386,857 | 386,857 | |||||||||
Other Current Liabilities* | 7,447 | 3,736 | 99.3 | 538 | 344 | 56.6 | ||||||||||||
Total Curr. Liab. | 28,290 | 7,141 | 296.2 | 2,045 | 657 | 211.2 | # Average Shares Outstanding | |||||||||||
Long-Term Debt | 1,755 | 13,975 | (87.4) | 127 | 1,286 | (90.1) | (thousands) | 358,505 | 358,538 | |||||||||
Other LT Liabilities | 726 | 1,687 | (57.0) | 52 | 155 | (66.2) | ||||||||||||
Total Liabilities | 30,771 | 22,802 | 35.0 | 2,225 | 2,098 | 6.0 | # Employees(5) | 19,385 | 24,442 | |||||||||
Majority interest | 1,882 | 7,425 | (74.7) | 136 | 683 | (80.1) | ||||||||||||
Minority Interest | 1,404 | 1,960 | (28.4) | 101 | 180 | (43.8) | ||||||||||||
Total Shar. Equity | 3,285 | 9,386 | (65.0) | 238 | 864 | (72.5) | ||||||||||||
(1) Financial data for year 2008 is presented in nominal pesos while for previous periods it is expressed in constant pesos as of December 31, 2007. For more details please refer to the note regarding new Mexican Financial Reporting Standards on page 2. | ||||||||||||||||||
(2) Financial ratios are calculated using figures in pesos | ||||||||||||||||||
(3) Investment in Affiliates includes 49.7% participation in Comegua under the equity method starting December 2008, as a result of the deconsolidation of Comegua. | ||||||||||||||||||
(4) Since we are not in full compliance under our bond indentures, the outstanding amount of the Senior Notes debt was reclassified from long-term to short-term | ||||||||||||||||||
(5) The total number of employees for 2008 does not include Comegua | ||||||||||||||||||
* Please refer to the Derivative Financial Instruments Situation section |
VITRO, S.A.B. DE C.V. AND SUBSIDIARIES | |||||||||||||||
SEGMENTED INFORMATION | |||||||||||||||
FOR THE PERIODS, (MILLION) | |||||||||||||||
Fourth Quarter | January - December | ||||||||||||||
Pesos (1) | Nominal Dollars | Constant Pesos | Nominal Dollars | ||||||||||||
2008 | 2007 | % | 2008 | 2007 | % | 2008 | 2007 | % | 2008 | 2007 | % | ||||
GLASS CONTAINERS | |||||||||||||||
Net Sales | 3,659 | 3,679 | -0.5% | 276 | 338 | -18.4% | 15,524 | 14,676 | 5.8% | 1,410 | 1,321 | 6.8% | |||
Interd. Sales | 13 | 7 | 101.2% | 1 | 1 | 65.1% | 40 | 37 | 9.0% | 4 | 3 | 9.9% | |||
Con. Net Sales | 3,646 | 3,672 | -0.7% | 275 | 337 | -18.5% | 15,484 | 14,639 | 5.8% | 1,406 | 1,317 | 6.8% | |||
Expts. | 870 | 979 | -11.1% | 77 | 90 | -14.1% | 4,179 | 4,027 | 3.8% | 383 | 365 | 5.1% | |||
EBIT | 330 | 705 | -53.2% | 25 | 65 | -61.0% | 1,661 | 2,085 | -20.3% | 152 | 188 | -18.7% | |||
Margin (2) | 9.1% | 19.2% | 9.2% | 19.2% | 10.7% | 14.2% | 10.8% | 14.2% | |||||||
EBITDA | 660 | 828 | -20.3% | 50 | 76 | -34.2% | 2,776 | 3,100 | -10.5% | 252 | 278 | -9.4% | |||
Margin (2) | 18.1% | 22.5% | 18.2% | 22.6% | 17.9% | 21.2% | 17.9% | 21.1% | |||||||
Glass containers volumes (MM Pieces) | |||||||||||||||
Domestic | 959 | 1,206 | -20.5% | 4,704 | 4,841 | -2.8% | |||||||||
Exports | 295 | 356 | -17.2% | 1,351 | 1,347 | 0.3% | |||||||||
Total:Dom.+Exp. | 1,254 | 1,562 | -19.7% | 6,055 | 6,187 | -2.1% | |||||||||
Soda Ash (Thousand Tons) | 162 | 163 | -0.8% | 659 | 636 | 3.6% | |||||||||
FLAT GLASS | |||||||||||||||
Net Sales | 3,401 | 3,423 | -0.7% | 256 | 313 | -18.0% | 13,230 | 13,605 | -2.8% | 1,195 | 1,212 | -1.4% | |||
Interd. Sales | 6 | 5 | 4.2% | 0 | 0 | -13.0% | 42 | 14 | 198.5% | 4 | 1 | 208.4% | |||
Con. Net Sales | 3,395 | 3,418 | -0.7% | 256 | 312 | -18.0% | 13,187 | 13,591 | -3.0% | 1,191 | 1,210 | -1.6% | |||
Expts. | 467 | 642 | -27.3% | 35 | 59 | -40.2% | 2,368 | 2,646 | -10.5% | 217 | 237 | -8.6% | |||
EBIT | (89) | 218 | -- | (6) | 20 | -- | 186 | 782 | -76.3% | 20 | 69 | -70.7% | |||
Margin (2) | -2.6% | 6.4% | -2.4% | 6.4% | 1.4% | 5.8% | 1.7% | 5.7% | |||||||
EBITDA | 90 | 331 | -72.7% | 7 | 30 | -75.9% | 789 | 1,320 | -40.3% | 74 | 116 | -36.5% | |||
Margin (2) | 2.7% | 9.7% | 2.8% | 9.7% | 6.0% | 9.7% | 6.2% | 9.6% | |||||||
Flat Glass Volumes (Thousand m2R) (3) | |||||||||||||||
Const + Auto | 31,816 | 33,871 | -6.1% | 133,089 | 132,790 | 0.2% | |||||||||
CONSOLIDATED (4) | |||||||||||||||
Net Sales | 7,166 | 7,201 | -0.5% | 540 | 660 | -18.2% | 29,096 | 28,643 | 1.6% | 2,635 | 2,565 | 2.7% | |||
Interd. Sales | 19 | 12 | 58.2% | 1 | 1 | 30.5% | 83 | 51 | 61.6% | 8 | 5 | 65.0% | |||
Con. Net Sales | 7,147 | 7,190 | -0.6% | 538 | 659 | -18.2% | 29,013 | 28,591 | 1.5% | 2,627 | 2,560 | 2.6% | |||
Expts. | 1,337 | 1,621 | -17.5% | 112 | 149 | -24.4% | 6,547 | 6,673 | -1.9% | 600 | 601 | -0.3% | |||
EBIT | 187 | 867 | -78.4% | 15 | 79 | -81.5% | 1,710 | 2,704 | -36.7% | 160 | 242 | -33.7% | |||
Margin (2) | 2.6% | 12.1% | 2.7% | 12.1% | 5.9% | 9.5% | 6.1% | 9.4% | |||||||
EBITDA | 772 | 1,100 | -29.8% | 59 | 101 | -41.8% | 3,605 | 4,379 | -17.7% | 329 | 391 | -15.9% | |||
Margin (2) | 10.8% | 15.3% | 10.9% | 15.3% | 12.4% | 15.3% | 12.5% | 15.3% | |||||||
(1) Financial data for year 2008 is presented in nominal pesos while for previous periods it is expressed in constant pesos as of December 31, 2007. For more details please refer to the note regarding new Mexican Financial Reporting Standards on page 2. | |||||||||||||||
(2) EBIT and EBITDA Margins consider Consolidated Net Sales. | |||||||||||||||
(3) m2R = Reduced Squared Meters | |||||||||||||||
(4) Includes corporate companies and other's sales and EBIT. |
Vitro, S.A.B. de C.V. (BMV: VITROA; NYSE: VTO), is one of the largest
glass manufacturers in the world. Through our subsidiary companies we offer
products with the highest quality standards and reliable services to satisfy the
needs of two distinct business sectors: glass containers and flat glass. Our
manufacturing facilities produce, process, distribute and sell a wide range of
glass products that offer excellent solutions to multiple industries that
include: wine, beer, cosmetic, pharmaceutical, food and beverage, as well as the
automotive and construction industry. Also, we supply raw materials, machinery
and industrial equipment to different industries. We constantly strive to
improve the quality of life for our employees as well as the communities in
which we do business by generating employment and economic prosperity thanks to
our permanent focus on quality and continuous improvement as well as consistent
efforts to promote sustainable development. Our World Headquarters are located
in Monterrey, Mexico where Vitro was founded in 1909 and now embarks major
facilities and a broad distribution network in ten countries in the Americas and
Europe. For more information, you can access Vitro's Website at:
http://www.vitro.com
For more
information, please contact:
Investor Relations
Adrian Meouchi /Angel Estrada
Vitro S.A.B. de C.V.
+ (52) 81-8863-1765 / 1730
ameouchi@vitro.com
aestradag@vitro.com
U.S. Agency
Susan Borinelli / Danielle Birrer
Breakstone Group
(646) 452-2336
sborinelli@breakstone-group.com
bcano@breakstone-group.com
Media Relations
Albert Chico/Roberto Riva
Vitro, S. A. B. de C.V.
+52 (81) 8863-1661/1689
achico@vitro.com
rriva@vitro.com
SIGNATURES
Pursuant
to the requirements of the Securities Exchange Act of 1934, the registrant has
duly caused this report to be signed on it's behalf by the undersigned,
thereunto duly authorized.
VITRO, S.A.B. DE C.V.
By
/s/ Claudio L. Del Valle Cabello
Name: Claudio L. Del Valle
Cabello
Title: Attorney in Fact
Date: March 30, 2009
1 Year Vitro Sociedad Chart |
1 Month Vitro Sociedad Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions